Loading...

PetMed Express, Inc.

PETSNASDAQ
HealthcareMedical - Pharmaceuticals
$3.96
$-0.01(-0.25%)

PetMed Express, Inc. (PETS) Stock Overview

Explore PetMed Express, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
9.42%
9.42%
Profit Growth
$0.02
3303.43%
EPS Growth
$0.02
3317.39%
Operating Margin
0.22%
470.77%
ROE
0.37%
3303.43%
Dividend Yield
0.00%
49.61%

Analyst Recommendations

Strong Buy
Buy
Hold
Sell
Strong Sell

Price Targets

Low$7.00
Average$7.00
High$7.00

Company Profile

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

CEO

Ms. Sandra Y. Campos

Employees

287

Headquarters

420 South Congress Avenue, Delray Beach, FL

Founded

1999

Frequently Asked Questions